Effect of electroconvulsive therapy (ECT) on plasma tryptophan

Area of Science:

• Neuroscience
• Biochemistry

Background:

• Unipolar depression is a complex mood disorder.
• Tryptophan is a precursor to serotonin, a key neurotransmitter implicated in mood regulation.
• The effect of electroconvulsive therapy (ECT) on plasma tryptophan levels in depression remains unclear.

Purpose of the Study:

• To investigate the impact of electroconvulsive therapy (ECT) on total and free plasma tryptophan concentrations in patients with unipolar depression.
• To examine the acute effects of anesthesia on plasma tryptophan levels using a control group.

Main Methods:

• Plasma samples were collected from 12 unipolar depressed patients before and after a course of ECT, and before and after individual ECT sessions.
• Eleven patients undergoing diagnostic cystoscopy served as controls to assess the acute effects of anesthesia.
• Total and free plasma tryptophan concentrations were measured using biochemical assays.

Main Results:

• No significant differences in total or free plasma tryptophan were observed between depressed patients and controls.
• A course of ECT did not significantly alter plasma tryptophan concentrations in depressed patients.
• Acutely, ECT and anesthesia significantly reduced total plasma tryptophan in depressed patients (P < 0.05) and anesthesia alone reduced it in controls (P < 0.01).
• Free plasma tryptophan levels were not significantly affected by ECT or anesthesia.

Conclusions:

• ECT treatment does not appear to alter baseline plasma tryptophan levels in unipolar depression.
• The acute reduction in total plasma tryptophan following ECT/anesthesia is likely attributable to the anesthetic agent, thiopental, potentially affecting tryptophan's binding to albumin.
• Further research is needed to elucidate the precise mechanisms underlying thiopental's effect on tryptophan binding.